CytoDyn (CYDY) Assets Average (2011 - 2026)

CytoDyn's Assets Average history runs 16 years deep, the most recent figure standing at $13.7 million for Q1 2026.

• Quarterly Assets Average fell 40.45% year-over-year to $13.7 million in Q1 2026, while the trailing twelve-month figure through Feb 2026 was $13.7 million (down 40.45% YoY) and the FY2025 annual result came in at $14.6 million, up 30.12% from the prior year.
• Assets Average was $13.7 million for Q1 2026 at CytoDyn, up from $11.2 million in the prior quarter.
• Across five years, Assets Average topped out at $98.9 million in Q1 2022 and bottomed at $9.8 million in Q1 2024.
• A 5-year average of $23.7 million and a median of $15.8 million in 2025 frame the typical range for Assets Average.
• Annual changes were most pronounced in 2023 — Assets Average sank 89.02% — and 2024, when it soared 144.32%.
• CytoDyn's Assets Average stood at $17.7 million in 2022, then tumbled by 38.96% to $10.8 million in 2023, then soared by 144.32% to $26.4 million in 2024, then slumped by 57.62% to $11.2 million in 2025, then gained by 22.37% to $13.7 million in 2026.
• Business Quant data shows CYDY's Assets Average at $13.7 million in Q1 2026, $11.2 million in Q4 2025, and $15.8 million in Q3 2025.